2021 Future Healthcare LP×GP Summit: Top Fund Partners Await You in Wujiang, Suzhou
Amid the shifting tides of industrial development, we have continually witnessed the wisdom and courage of innovative entrepreneurs, as well as the ups and downs of publicly listed companies, while personally experiencing how capital forces are reshaping the entire healthcare industry. The outbreak of the COVID-19 pandemic in 2020 served as a test for the entire healthcare industry system and also influenced new trends in capital allocation. In the aftermath of this turmoil, where is the industry headed? How will competition unfold across niche sectors within healthcare? What insights into market sentiment do successful fundraising rounds by new funds reveal about investors’ judgments?
April 17，VCBeat, Yangtze River Delta Integration Demonstration Zone (Suzhou) Venture Capital Service Co., Ltd.Co-hosted by2021 Future Healthcare Fund Partners (LP-GP) SummitScheduled forSuzhou · Wujiang · Suzhou Bay Venture Capital Baseheld. As a parallel summit of the VCBeat 2020-2021 Top 100 Future Healthcare Companies Conference, the LP-GP Summit will build a high-quality dialogue platform for partners of top-tier healthcare funds and leading enterprises in the global health industry, focusing on"Innovation-Driven + Capital-Linked + Self-Evolving"This theme, adopting“Keynote Speech + Roundtable Dialogue + Featured Roadshow + Open Networking”interactive format, jointly discussing value creation and value investment in the global healthcare industry.
Click the link or scan the QR code to purchase tickets
Through keynote speeches, roundtable discussions, dedicated roadshows, and open networking sessions, the event facilitates LP-GP resource matchmaking, establishing a platform for information exchange, resource alignment, and relationship management between Limited Partners (LPs) and General Partners (GPs).
We have specially invited VIP attendees from the 2020 Future Healthcare Top 100, including Annual Investment Institutions, Annual Corporate Venture Capital (CVC) Firms, Annual Investors, Enterprises of the Year, Leading Enterprises of the Year, and Outstanding Industry Guidance Funds in the Healthcare Sector. All other registrants must undergo a qualification review to participate in this high-end, precise, closed-door summit.
The summit will invite partners from top-tier healthcare investment funds to explore value creation in the healthcare industry by examining the intrinsic innovation-driven forces of enterprises; to discuss value discovery in the healthcare sector by analyzing emerging external capital trends; and, building on these foundations of value creation and discovery, to examine the evolving investment strategies and management practices of healthcare fund partners.
(The agenda will be dynamically updated as speakers are confirmed; the final agenda is subject to change on-site.)
Part One: The Boiling Years
Keynote Speech: Innovation and Breakthroughs in the Development Model of Fund-of-Funds Under the New Venture Capital Ecosystem
Invite leading domestic fund-of-funds (FoF) managers to share insights and engage in discussions on the historical development, current landscape, investment focus within the healthcare sector, general partner (GP) selection, FoF operations, and direct investments by FoFs. The session will highlight innovations and breakthroughs amid the current challenges and opportunities facing the FoF industry.
Part Two: The Intelligent Investor
Keynote Address: Accelerating Innovation in Medical Devices—A Comprehensive Deconstruction of Institutional Investment Logic
Invite outstanding fund managers investing in China’s medical device industry to analyze their investment logic in the broader healthcare sector, with a focus on sharing experiences in fundraising, investment, portfolio management, and exit strategies; key sectors of interest and investment; strategic layout in niche sub-sectors; and notable investment/exit case studies.
Part Three: Reconstructing Aesthetics
Roundtable Discussion: Exploring the Chinese-Style LP-GP Relationship in Healthcare and Life Sciences
Four leading Chinese LPs and GPs were invited to discuss the current LP-GP dynamics in China, building on the principles of value discovery and value investing in the healthcare sector. The discussion focused on how to strike an optimal balance between LPs and GPs—maintaining a “beautiful distance”—to enhance fund management and operations, particularly against the backdrop of increasing direct investments by fund-of-funds, tighter fundraising conditions for GPs, and the widening gap between cooling investment activity and heated market sentiment.
Part Four: The Great Game
Roundtable Discussion: Review of the 2020 IPO Market for Healthcare Companies and Future Outlook
Four distinguished guests, including partners from leading domestic general partnership (GP) firms and executives of publicly listed companies, were invited to review the global initial public offerings (IPOs) of Chinese healthcare companies in 2020 from the perspective of primary and secondary capital market performance. The discussion focused on the fundraising journeys, IPO decisions, and market performance of representative cases, while also analyzing and forecasting the most promising sectors and IPO pathway choices for Chinese healthcare companies over the next decade.
Part Five: The Singularity Is Near
Roundtable Discussion: The Debate on CVC Healthcare Investment
Four global healthcare CVC investors will be invited to discuss the multifaceted impact on innovative companies within the sector, against the backdrop of tech giants accelerating their CVC investment activities. The discussion will focus on analyzing the strategic layouts and investment strategies of leading Chinese corporations’ CVC arms in the healthcare industry, and critically examine how these investments both facilitate and hinder portfolio companies in areas such as value chain extension, industry resource integration, project valuation, and business expansion.
Part Six: GP Roadshow
3 GP and Post-Investment Project Roadshows
Three specialized roadshows will break away from the traditional format of project pitches. Rather than merely connecting innovative enterprises with investment institutions, they will deepen engagement across the triad of innovative enterprises, investment institutions, and fund-of-funds (FOFs). Adopting a comprehensive pitching model of “1 GP + 2 portfolio companies,” these sessions will not only showcase high-quality portfolio companies to investors but also present the institution’s overall investment strategy and sector allocation to Limited Partners (LPs).
(1) Various funds of funds (FoFs) investing in the healthcare industry: market-oriented FoFs and government-guided funds globally investing in the healthcare sector, which must manage capital available for investment in China and have experience in investing in VC/PE funds or making direct investments in healthcare projects.
(2) Investment institutions investing in the healthcare industry: Global angel investment, venture capital, and private equity firms that invest across the entire healthcare sector must have established and manage funds dedicated to healthcare investments.
(3) Listed companies in the healthcare industry: Domestic and overseas listed healthcare enterprises and groups that manage industrial investment funds targeting projects within the sector, or large medical groups seeking to adjust their strategic development pace through mergers and acquisitions.
(4) Innovators in the Healthcare Industry: Third-party service providers, entrepreneurs and innovators, and distinguished media professionals focused on value creation and value investment in the global healthcare industry.
LP-GP Forum Business Cooperation Contact
LP-GP Forum Consultation
Click the link or scan the QR code to purchase tickets